TY  - GEN
AU  - Toma,S
AU  - Raffo,P
AU  - Nicolo,G
AU  - Canavese,G
AU  - Margallo,E
AU  - Vecchio,C
AU  - Dastoli,G
AU  - Iacona,I
AU  - Regazzi-Bonora,M
TI  - Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients
SN  - 1019-6439
PY  - 2000///1205
KW  - Aged
KW  - Aneuploidy
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Area Under Curve
KW  - Bone Marrow Diseases
KW  - chemically induced
KW  - Breast Neoplasms
KW  - chemistry
KW  - Carcinoma
KW  - Drug Administration Schedule
KW  - Drug Interactions
KW  - Female
KW  - Follow-Up Studies
KW  - Headache
KW  - Humans
KW  - Hypercholesterolemia
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - administration & dosage
KW  - Ki-67 Antigen
KW  - analysis
KW  - Mastectomy
KW  - Middle Aged
KW  - Neoplasm Proteins
KW  - Receptors, Retinoic Acid
KW  - Receptors, Steroid
KW  - Recombinant Proteins
KW  - Safety
KW  - Tamoxifen
KW  - Transforming Growth Factor beta
KW  - Transforming Growth Factor beta1
KW  - Treatment Outcome
KW  - Tretinoin
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3892/ijo.17.5.991
ER  -